Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis.

Wang Z, Zhang Y, Chai J, Wu Y, Zhang W, Zhang Z

Open source

DOI
10.1016/j.jad.2023.12.074
Published
2024 Apr 1
Container
Journal of affective disorders
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jad.2023.12.074,
  title = {Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis.},
  author = {Wang Z and Zhang Y and Chai J and Wu Y and Zhang W and Zhang Z},
  year = {2024},
  journal = {Journal of affective disorders},
  doi = {10.1016/j.jad.2023.12.074},
  url = {https://doi.org/10.1016/j.jad.2023.12.074}
}

RIS

TY  - JOUR
TI  - Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis.
AU  - Wang Z
AU  - Zhang Y
AU  - Chai J
AU  - Wu Y
AU  - Zhang W
AU  - Zhang Z
PY  - 2024
JO  - Journal of affective disorders
DO  - 10.1016/j.jad.2023.12.074
UR  - https://doi.org/10.1016/j.jad.2023.12.074
ER  - 

APA

Z, W., Y, Z., J, C., Y, W., W, Z., & Z, Z. (2024). Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis.. Journal of affective disorders. https://doi.org/10.1016/j.jad.2023.12.074

Source records